Related Experiment Video

Updated: May 15, 2026

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

Ubiquitin pathway and ovarian cancer

Z Rao1, Y Ding

  • 1Department of Gynecology and Obstetrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, PR China.

Current Oncology (Toronto, Ont.)
|January 10, 2013
PubMed

Insights

The ubiquitin-proteasome pathway regulates cellular processes and is implicated in ovarian cancer. This review details its role in modulating key genes and pathways involved in tumor growth.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The ubiquitin-proteasome pathway (UPP) is a fundamental cellular mechanism for protein degradation in eukaryotes.
  • UPP regulates critical cellular functions including cell cycle, transcription, apoptosis, and angiogenesis.
  • Dysregulation of UPP is linked to various diseases, including cancer.

Purpose of the Study:

  • To review the involvement of the ubiquitin-proteasome pathway in the development and progression of ovarian cancer.
  • To highlight how UPP influences key molecular players and signaling pathways in ovarian cancer.

Main Methods:

  • Literature review of studies investigating the ubiquitin-proteasome pathway in ovarian cancer.
  • Analysis of UPP's role in regulating specific genes (e.g., BRCA1, p53, ERBB2) and pathways (e.g., erk, cell cycle).

Main Results:

  • UPP modulates the ovarian cancer-related gene BRCA1 and the tumor suppressor p53.
  • The pathway interferes with the erk pathway, cyclin-dependent cell cycle regulation, and ERBB2 gene expression.
  • UPP's activity is crucial for regulating processes that drive tumor growth and angiogenesis in ovarian cancer.

Conclusions:

  • The ubiquitin-proteasome pathway is a significant factor in ovarian cancer pathogenesis.
  • Targeting UPP components may offer novel therapeutic strategies for ovarian cancer treatment.
Keywords:
Ubiquitingene expressionovarian cancerprotein degradationtherapy

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...